Brief: Aft Pharmaceuticals Retains Its Guidance For An Operating Profit For Year To 31 March 2022 Of NZ$18 Million To NZ$23 Million
06/01/2022 21:31
Jan 7 (Reuters) - AFT Pharmaceuticals:
* RETAINS ITS GUIDANCE FOR AN OPERATING PROFIT FOR YEAR TO
31
MARCH 2022 OF NZ$18 MILLION TO NZ$23 MILLION
Further company coverage: AFT.NZ
((Reuters.Briefs@thomsonreuters.com;))
Recent news on AFT Pharmaceuticals
See all newsNZ's AFT Pharma eyes highest weekly gain in over 2 months after results
Brief: AFT Pharmaceuticals Reports Double Digit Revenue Growth In 1H FY27
NZ's AFT Pharmaceuticals gains most in over 2 weeks on strong half-year results
Brief: AFT Pharmaceuticals Enters Exclusive Development, License And Supply Agreement With Mikasaseiyaku
NZ's AFT Pharma rises to near 1-month high on Japan licensing deal for Maxigesic IV